Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levofloxacin prophylaxis to prevent febrile neutropenia during cytarabine consolidation in acute myeloid leukemia
TCTR20240401009Phase 3Completed
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in acute myeloid leukemia (AML), sponsored by none. Started Jul 2022; status: completed.
02
Drugs
levofloxacin
03
Conditions
acute myeloid leukemia (AML)
Beyond the preview
Go deeper on TCTR20240401009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240401009.